First, China's health insurance system is not yet perfect, and hospitals usually make up for losses in medical services by making profits from drug sales. As a result, hospitals often resort to various means to increase the quantity and specifications of drugs prescribed, thereby boosting drug sales. This also leads to problems such as over-prescribing and over-medication by doctors.
Secondly, production costs in China's drug industry are relatively high. For example, raw materials for Chinese drugs often need to be imported, and the level of technology and equipment of domestic producers needs to be improved. At the same time, costs and overheads in the drug production process are also relatively high, and all these factors can lead to higher drug prices.
Finally, China's drug market is not sufficiently competitive. Although the government has introduced a number of policies to promote market competition, there are still many enterprises that lack a sense of competition, drug prices are not transparent, market access barriers and other problems still exist, which also leads to high drug prices.
Therefore, to solve the problem of high drug prices in China, it is necessary to start from many aspects, such as government regulation, medical insurance system, and competition in the drug market, to implement comprehensive measures to promote the rationalization and reduction of drug prices. At the same time, it is also necessary for consumers to improve their own drug selection and medication awareness, not blindly follow the trend of buying expensive drugs, thereby reducing medical expenditure.